Organon OGN
NYSE OGN
$13.89 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Organon (OGN) Cash from Discontinued Operations (2020 - 2021)

Updated

Organon's Cash from Discontinued Operations was $298 million in FY2021, compared with -$97 million in FY2020.

Analysis

Organon (OGN) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends

  • Per Business Quant data, Cash from Discontinued Operations in earlier years was -$97 million in FY2020 and -$253 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Organon 3.65 Bn -629.18 Mn 869.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 94.00 Mn
Mar 31, 2021 204.00 Mn
Dec 31, 2020 -54.00 Mn
Sep 30, 2020 -32.00 Mn
Jun 30, 2020 70.00 Mn
Mar 31, 2020 -81.00 Mn
API Access

Organon Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=OGN&period=max&api_key=YOUR_API_KEY